NRK cells transformed by the McDonough strain of feline sarcoma virus (SM-FeSV) were mutagenized by the use of 5'-azacytidine. Four cell lines expressing different transformation-defective phenotypes were isolated. Superinfection of these cell lines with simian sarcoma-associated virus (SSAV) led in three instances to the recovery of transforming virus particles carrying an intact fms gene. A nonconditional transformationdefective virus, designated td26-SM-FeSV (SSAV), was isolated from one of the cell lines. NRK cells infected with this mutant contained actin cables and fibronectin networks and exhibited normal cell morphology. Such cells formed only small colonies in soft agar and exhibited a mitogenic activity similar to that of noninfected cells. Cells infected with td26-SM-FeSV (SSAV) synthesized a gag-fms fusion glycoprotein (gplj9ag-fms). This polypeptide was processed in the normal manner into the intracellular gpl2Ov-fms and a transformationdefective gp14Otd-v-fms which was expressed at the surface of infected cells. This species had an increased electrophoretic mobility on polyacrylamide gels compared with the molecule from wild-type virus. gp14Otd-v-fms had endo-o-N-acetylglucosaminidase H-resistant carbohydrate side chains. No tyrosine kinase activity was detectable in vivo in td26-SM-FeSV (SSAV)-infected cells even when the cells were treated with sodium orthovanadate. In vitro, fms molecules from td26-SM-FeSV (SSAV)-infected cells exhibited tyrosine kinase activity as determined by autophosphorylation and phosphorylation of exogenous (poly)Glu-Tyr. At low ATP concentrations (<5 ,uM) this in vitro tyrosine kinase activity was significantly reduced compared with that of the wild-type counterpart.
The McDonough strain of feline sarcoma virus (SM-FeSV) encodes a gag-fms fusion protein (gpl80f"') which exhibits the typical features of a transmembrane glycoprotein; it is cotranslationally N glycosylated and processed by proteolytic cleavage to generate p55g"'i' and gp120v-fP?ls. gp120v-fms is specified entirely by the viral oncogene v-fms and remains associated with the membranes. About 10 to 15% of the molecules are transported via the Golgi apparatus to the plasma membrane and are concomitantly processed by additional glycosylation of the amino-terminal domain to yield gpl4O-fms (1, 11, 12) . Cell surface expression of the glycoprotein is a prerequisite for cell transformation (13) .
The extracellular domain of gp140v-rfts binds the colonystimulating factor (CSF-1) of macrophages (14, 15) . The cytoplasmic domain of the fms gene product shows partial sequence homology with other members of the src family (5) and exhibits tyrosine kinase activity. In vivo, however, this activity can be detected only in the presence of sodium orthovanadate, an inhibitor of tyrosine-specific phosphatases (19) .
In this report, we describe the isolation of cell lines which synthesize afms gene product but express a transformationdefective phenotype. Using simian sarcoma-associated virus (SSAV) as a helper virus, a nonconditional transformationdefective virus, designated td26-SM-FeSV (SSAV), was recovered from such cells. Cells infected with td26-SMFeSV (SSAV) failed to become transformed as judged by the cell morphology, by the mitogenic activity, and by growth in soft agar. These cells expressed a v-fms polypeptide at the plasma membrane. The Antisera. SM-NRK cells (106) were injected subcutaneously into 3-to 5-day-old rats. A tumor of 1-cm diameter was palpable at the injection site within 14 days and regressed completely within 4 weeks. The same number of cells were injected again 6 to 8 weeks after the first inoculation. Rats were bled 2 weeks after the final booster. For immunofluorescence studies, the serum was absorbed three times with rat liver acetone powder (Sigma, Munich, Federal Republic of Germany) and three times with 108 NRK cells and used at a dilution of 1 to 60.
Radiolabeling of transformed cells. Confluent SM-NRK cells in 3.5-cm petri dishes were labeled for 6 h with a 100-,uCi/ml solution of [3H]leucine (55 Ci/mmol), [6-3H] glucosamine hydrochloride ( Immunoprecipitation and kinase assay. Cells were lysed in lysis buffer (10 mM [Na2HPO4-NaH2PO4], 10 mM EDTA, 40 mM NaF, 1% Triton X-100, 5% Trasylol [pH 7.0]), and immunoprecipitations with protein A-bearing Staphylococcus aureus were performed as described previously (18) . To demonstrate in vitro phosphorylation, S. aureus-bound immune complexes were rinsed with washing buffer (lysis buffer containing 1 M NaCl and only 0.2% Triton X-100). In vitro kinase reactions of v-fms polypeptides were performed in 20 mM Bis-Tris-Propane, pH 6.0, containing 10 mM MnCl2 and 3 ,uCi of [y-32P]ATP (3,000 Ci/mmol; Amersham Corp., Braunschweig, Federal Republic of Germany) in the presence of various concentrations of unlabeled ATP for the times indicated at room temperature. The reaction was stopped by dilution with 1 ml of quench buffer (100 mM Na2HPO4, 10 mM EDTA, 40 mM NaF, 1 mM ATP) or sample buffer and analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) by the method of Laemmli (9) .
Differential immunoprecipitation. Immunoprecipitation of cell surface-associated and cytoplasmic antigens was performed essentially as described by Soderquist and Carpenter (17) . Cells were grown in 3.5-cm petri dishes. After three washes with DMEM to remove all fetal calf serum, 300 ,ul of serum-free DMEM was added and cells were transferred onto ice. A saturating amount (20 (Fig. 3c) . In contrast, cells infected with td26-SMFeSV (SSAV) (Fig. 3b) formed significantly smaller colonies with only 1/10 as many cells as were present in wild-typetransformed cell colonies. These findings indicate that the td26-SM-FeSV (SSAV)-infected cells resembled normal cells in terms of cell morphology, mitogenic activity, and anchorage dependency.
Synthesis and glycosylation offms polypeptides in td26-SMFeSV (SSAV)-infected NRK cells. To study the biosynthesis offms-specific molecules in td26-SM-FeSV (SSAV)-infected NRK cells, we performed pulse-chase experiments using sister cultures of NRK cells infected with wt-SM-FeSV (SSAV) (Fig. 4a) or with td26-SM-FeSV (SSAV) (Fig. 4b) . Cell lysates were prepared at the times indicated, and samples were precipitated with polyclonal anti-fms rat serum and analyzed by SDS-PAGE. These results indicate that the three fms-specific molecules were synthesized in the same proportion and with the same kinetics in both cell lines. In addition, the half-life of gp14Otd-v-fins was about 4 h and thus was unaltered from that of the corresponding species in J. VIROL. Recent studies of the effe inhibitors had indicated that t fms molecule is a prerequisit (4). To determine whether th molecules was altered, uninfe infected with wt-SM-FeSV (SSAV) were metabolically I As shown in Fig. 4c, gpl4Otd faster on SDS-polyacrylamid species from wt-SM-FeSV ( Since both species could be shown) and contained carbol treatment with endo-p-N-acel (Fig. 4d) (Fig. 5a, lane 1) , while gp18VJa9-fms, gp12Ov-fe5s, and some gpl4Ov-fms species were present in the cytoplasmic fraction (lane 2). Figure Sb (lane 1) shows that gp140tdvfms was also expressed at the cell surface. Again, (Fig. 4a) 1%. exogenous substrate. The products of duplicate kinase reactions were subjected to SDS-PAGE and analyzed by Cerenkov counting. The data summarized in Fig. 8 show that no differences in the kinase activities were observed at ATP concentrations greater than 20 ,uM (Fig. 8a) . However, at concentrations of 0.3, 1.2, or 5.0 ,uM ATP, significantly lower levels of kinase activity were measured for immune complexes derived from td26-SM-FeSV (SSAV)-infected cells (Fig. 8b) , yielding a 2.5-fold-weaker phosphorylation at 1.2 ,uM ATP than in the wild-type counterpart.
In vivo tyrosine kinase activity of fms polypeptides. We have shown previously that the tyrosine kinase activity of fms molecules can be demonstrated in vivo only in the presence of sodium orthovanadate, an inhibitor of tyrosine phosphatases (19) . To determine the in vivo phosphorylation pattern of the mutant fms polypeptides, sister cultures of wt-SM-FeSV (SSAV)-and td26-SM-FeSV (SSAV)-infected cells were labeled with 32Pi for 7 h and lysed with lysis buffer containing 500 ,uM sodium orthovanadate. Cell lysates, each containing 2.5 x 107 cpm, were immunoprecipitated with tumor-bearing-rat serum and analyzed by SDS-PAGE. As to be expected from our previous data (19) , the plasma membrane-associated gpl4Ov-fms was phosphorylated about 30-fold stronger than the intracellular species gpl2Ov-fms. Under such conditions, we were unable to demonstrate any in vivo phosphorylation of gpl8Ov-fms. No difference could be detected in the phosphorylation pattern obtained from cells infected with wt-SM-FeSV (SSAV) (Fig. 7b, lane 2) or cells infected with td26-SM-FeSV (SSAV) (lane 3). Phosphoamino acid analyses performed on the individual gpl4Ov-fms molecules, however, revealed a different phosphoamino acid composition, as shown in Fig. 7c . In contrast to gpl4Ov-fms To analyze whether the lack of autophosphorylation in vivo had consequences for the tyrosine phosphorylation of yet undefined cellular target proteins, we determined the levels of total cellular phosphotyrosine as described previously (19) and detailed in the legend to Fig. 9 . The transformation-defective-virus-infected cells did not contain detectable levels of phosphotyrosine (panel 3) and resembled noninfected cells in this respect (panel 1). In agreement with previous results (19) , wt-SM-FeSV (SSAV)-infected cells showed about a fourfold increase in phosphotyrosine (panel 2).
DISCUSSION
The aim of this study was to establish transformationdefective cell lines and virus particles that could be used to gain further insight into the molecular mechanisms of cell transformation mediated by the fms oncogene product of SM-FeSV. The approach described here involved mutagenesis of nonproducer SM-FeSV-transformed NRK cells, selection of morphologically revertant cell clones, and superinfection of individual clones with the helper virus SSAV.
Four cell clones were isolated that could be differentiated according to morphologic, mitogenic, and anchorage-depen- (Table 1) . Our observation that SM-FeSV-transformed NRK cells lack organized actin cables seems to be in conflict with a previous report (1) and our own observation that actin cables are present in SM-FeSVtransformed mink cells. The disappearance in SM-FeSVtransformed NRK cells may, therefore, be a cell typespecific phenomenon.
All of the clones synthesized the typical pattern of fmsspecific polypeptides. Southern hybridization of EcoRI-digested chromosomal DNA with gag-orfns-specific probes yielded transforming virus particles encoding a functional fms protein with tyrosine kinase activity. These findings indicate that expression of the v-fms gene alone is not sufficient to maintain the transformed phenotype. The reversion of these mutant cell lines to normal phenotype could be interpreted in two ways. The cells could carry mutations in genes coding for yet undefined cellular proteins which should play a role in the chain of events leading to cell transformation and could constitute target proteins of the fms-specific tyrosine kinase. Alternatively, silent genes could have become activated by inhibition of cytosine methylation (8) . Whatever explanation is correct, the revertant cell lines will be helpful in future studies to elucidate the transformation mechanism induced by v-fms.
In contrast to these former three cell clones, td26 cells yielded pseudotype SSAV-particles carrying the transformation-defective effect directly in the fms gene. Cells infected with td26-SM-FeSV (SSAV) synthesized the gp1809a-f" precursor and its cotranslational cleavage product gpl20vfms. The kinetics of synthesis, as well as half-life, of these molecular species was the same as in SM-FeSVtransformed cells. The transport of gpl20vfms to the plasma membrane was not inhibited. However, the electrophoretic mobility of the gpl40td-v-fms species expressed at the surface of such cells was increased when compared with that of the gpl40vfms from wt-SM-FeSV (SSAV)-infected cells, indicating a different posttranslational modification of gpl40td-v-fms.
We have demonstrated previously that the precise glycosylation of the ectodomain of the fms glycoprotein is required to cause cell transformation (4). However, there are two lines of evidence indicating that the alteration of the electrophoretic mobility of gpl40td-v-fms is not due to differences in glycosylation. First, the molecular weights of gpl20 and gpl80 are identical in wild-type-and transformationdefective-virus-infected cells, indicating that no glycosylation sites are deleted. Second, similar to the transformation-active glycoprotein, gpl40td-v-fms molecules contain endo-H-resistant side chains that can be metabolically labeled with fucose. We cannot exclude, however, that an altered tertiary structure of the td-fms molecule has consequences for the ratio of biantennary or triantennary carbohydrate structures. Additional phosphorylation could also explain the increase in electrophoretic mobility. Other growth factor receptors, such as the insulin receptor or the epidermal growth factor receptor, have been reported to be down regulated by protein kinase C (16). We have reported previously that gpl40vfms is phosphorylated in serine and tyrosine 30-fold more strongly than the intracellular fms species are (19) . So far, however, we were unable to demonstrate qualitative differences in the phosphorylation patterns of Pi-labeled gpl40vf"s molecules derived from cells infected with td26-SM-FeSV (SSAV) or wt-SM-FeSV (SSAV) as determined by Cleveland mapping (3) (data not shown).
The transformation-defective effect of the fms molecule affected the in vitro kinase activity, as shown by autophosphorylation and phosphorylation of poly(Glu-Tyr) at low ATP concentrations. We show here that the kinase activity of the td-fms molecules was about 2.5-fold weaker than determined for the wild-type counterparts at 1.2 ,uM ATP, suggesting a lower affinity of the td-fms molecules. At present, it is unclear whether this reduced affinity accounts for the lack of in vivo kinase activity determined for td26-SM-FeSV (SSAV)-infected cells. The in vivo tyrosine kinase activity seems to be a prerequisite for cell transformation. It is suggested that the fms polypeptide present at the plasma membrane phosphorylates one or more target proteins that transmit the signals for cell proliferation and morphological changes. In this respect, it is noteworthy that the in vivo tyrosine kinase activity of the fms polypeptides is about fivefold weaker than the activity associated with other members of the tyrosine kinase family, as determined by the amount of phosphotyrosine in cellular proteins (19) . We believe that this situation reflects a more restricted substrate specificity of the fms kinase, allowing us to identify these substrates in the future.
